"There is nothing else in the health-care field
that can do
what a good prescription drug can do--on the money side.
It is a business to be envied by all." --New York Times, July 28,
1989
Economics, as much as medical science, drives the direction of cancer
research and treatment. This thesis, which was controversial when I first
stated it in The Cancer Syndrome, has since become commonplace, and hardly
worth arguing.
One of the reasons I started The Cancer Chronicles, however, was to provide
a kind of running commentary, an instant update, on the link between business
and cancer. Here are ten articles from The Cancer Chronicles on how economics
and cancer interact:
